WallStreetZenWallStreetZen

NASDAQ: ELEV
Elevation Oncology Inc Stock Ownership - Who owns Elevation Oncology?

Insider buying vs selling

Have Elevation Oncology Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2024-06-164,628$3.23
$14.95kSell
Tammy FurlongCHIEF FINANCIAL OFFICER2024-05-15100$3.73
$373.00Sell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2024-03-164,773$4.39
$20.95kSell
Tammy FurlongCHIEF FINANCIAL OFFICER2024-02-15403$2.77
$1.12kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2023-12-164,773$0.51
$2.43kSell
Joseph J. Ferra Jr.CHIEF EXECUTIVE OFFICER2023-09-164,773$0.73
$3.47kSell

1 of 1

ELEV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELEV insiders and whales buy or sell their stock.

ELEV Shareholders

What type of owners hold Elevation Oncology Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Farallon Capital Management LLC7.11%3,886,663$11.64MInstitution
Point72 Asset Management LP6.16%3,368,200$10.09MInstitution
Tang Capital Management LLC5.60%3,060,000$9.16MInstitution
Balyasny Asset Management LP5.59%3,055,479$9.15MInstitution
Aisling Capital Management LP5.19%2,834,910$8.49MInstitution
Aisling Capital Iv LP5.19%2,834,910$8.49MInsider
Venbio Partners LLC4.93%2,696,133$8.07MInstitution
Braidwell LP4.35%2,377,647$7.12MInstitution
Qiming Us Healthcare Fund Ii LP4.34%2,370,142$7.10MInsider
Darwin Global Management Ltd4.27%2,332,928$6.99MInstitution

1 of 3

ELEV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELEV78.86%21.14%Net SellingNet Selling
KOD68.53%31.47%Net SellingNet Selling
VIGL45.53%54.47%Net Buying
RPTX60.47%39.53%Net Buying
GALT8.77%91.23%Net BuyingNet Selling

Elevation Oncology Stock Ownership FAQ

Who owns Elevation Oncology?

Elevation Oncology (NASDAQ: ELEV) is owned by 80.53% institutional shareholders, 21.58% Elevation Oncology insiders, and 0.00% retail investors. Aisling Capital Iv LP is the largest individual Elevation Oncology shareholder, owning 2.83M shares representing 5.19% of the company. Aisling Capital Iv LP's Elevation Oncology shares are currently valued at $8.19M.

If you're new to stock investing, here's how to buy Elevation Oncology stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.